{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:40:23Z","timestamp":1790293223691,"version":"4.1.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2022.960829","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:46:07Z","timestamp":1656593167000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Editorial: The Role of Microorganisms in Multiple Myeloma"],"prefix":"10.3389","volume":"13","author":[{"given":"Maria","family":"Linares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Hermouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-692954","article-title":"MGUS to Myeloma: A Mysterious Gammopathy of Underexplored Significance","volume":"128","author":"Dhodapkar","year":"2016","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal Immunoglobulin Against Lysolipids in the Origin of Myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98259","article-title":"Antigen-Mediated Regulation in Monoclonal Gammopathies and Myeloma","volume":"3","author":"Nair","year":"2018","journal-title":"JCI Insight"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1190976","article-title":"Epstein\u2013Barr Virus Infection Is Associated to Patients With Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance","volume":"58","author":"Mameli","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017121319","article-title":"The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases","volume":"29","author":"Sethi","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.04.026","article-title":"A Fresh Perspective on Monoclonal Gammopathies of Renal Significance","volume":"6","author":"Aucouturier","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061562","article-title":"From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance","volume":"14","author":"Visentin","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051254","article-title":"Characteristics of MGUS and Multiple Myeloma According to the Target of Monoclonal Immunoglobulins, Glucosylsphingosine, or Epstein-Barr Virus EBNA-1","volume":"12","author":"Bosseboeuf","year":"2020","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020438","article-title":"Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens","volume":"10","author":"Harb","year":"2021","journal-title":"Cells"},{"key":"B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9151-8_1","article-title":"Origin and Pathogenesis of B Cell Lymphomas","volume-title":"Lymphoma","author":"Seifert","year":"2019"},{"key":"B12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1084\/jem.20121801","article-title":"A Mutated B Cell Chronic Lymphocytic Leukemia Subset That Recognizes and Responds to Fungi","volume":"210","author":"Hoogeboom","year":"2013","journal-title":"J Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010029","article-title":"Exploring the Pathways to Chronic Lymphocytic Leukemia","volume":"138","author":"Stevenson","year":"2021","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1038\/s41467-018-07305-8","article-title":"Microbiota-Driven Interleukin-17-Producing Cells and Eosinophils Synergize to Accelerate Multiple Myeloma Progression","volume":"9","author":"Calcinotto","year":"2018","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.919988","article-title":"Fecal Microbiota Taxonomic Shifts in Chinese Multiple Myeloma Patients Analyzed by Quantitative Polimerase Chain Reaction (QPCR) and 16S rRNA High-Throughput Sequencing","volume":"25","author":"Zhang","year":"2019","journal-title":"Med Sci Monit"},{"key":"B16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40168-020-00854-5","article-title":"Alterations of Gut Microbiome Accelerate Multiple Myeloma Progression by Increasing the Relative Abundances of Nitrogen-Recycling Bacteria","volume":"8","author":"Jian","year":"2020","journal-title":"Microbiome"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28479","article-title":"Common Community-Acquired Infections and Subsequent Risk of Multiple Myeloma: A Population-Based Study: Infections and Multiple Myeloma","volume":"134","author":"McShane","year":"2014","journal-title":"Int J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12742","article-title":"Hepatitis C Virus Infection and Risk of Multiple Myeloma: Evidence From a Meta-Analysis Based on 17 Case-Control Studies","volume":"24","author":"Li","year":"2017","journal-title":"J Viral Hepat"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13563","article-title":"Autoimmune Disease Is Associated With a Lower Risk of Progression in Monoclonal Gammopathy of Undetermined Significance","volume":"106","author":"Baldursdo\u00edttir","year":"2021","journal-title":"Eur J Haematol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200301093480219","article-title":"Hepatitis C Virus, Human Herpesvirus 8, and the Development of Plasma-Cell Leukemia","volume":"348","author":"Hermouet","year":"2003","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-167569","article-title":"Hepatitis C Virus (HCV) Infection, Monoclonal Immunoglobulin Specific for HCV Core Protein, and Plasma-Cell Malignancy","volume":"112","author":"Bigot-Corbel","year":"2008","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.07.001","article-title":"A Retrospective Analysis of Ten Symptomatic Multiple Myeloma Patients With HIV Infection: A Potential Therapeutic Effect of HAART in Multiple Myeloma","volume":"38","author":"Li","year":"2014","journal-title":"Leuk Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of Splenic Lymphoma With Villous Lymphocytes After Treatment of Hepatitis C Virus Infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.lrr.2013.01.002","article-title":"Regression of a Case of Multiple Myeloma With Antiviral Treatment in a Patient With Chronic HCV Infection","volume":"2","author":"Panfilio","year":"2013","journal-title":"Leuk Res Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1389","article-title":"Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct-Acting Antivirals","volume":"3","author":"Ioannou","year":"2019","journal-title":"Hepatol Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i13.3773","article-title":"Helicobacter Pylori Eradication in Gastric Diffuse Large B Cell Lymphoma","volume":"21","author":"Paydas","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.12.005","article-title":"Hepatitis B Virus-Associated B-Cell non-Hodgkin Lymphoma in non-Endemic Areas in Western Europe: Clinical Characteristics and Prognosis","volume":"80","author":"Lemaitre","year":"2020","journal-title":"J Infect"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2019.05.007","article-title":"Splenic Marginal Zone Lymphoma Associated With Hepatitis B Virus Infection, Remission After Viral Treatment, and Splenectomy: A Case Report and Review of the Literature","volume":"14","author":"Ababou","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-283895","article-title":"A Novel Role of IL-17-Producing Lymphocytes in Mediating Lytic Bone Disease in Multiple Myeloma","volume":"116","author":"Noonan","year":"2010","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019032276","article-title":"Minimal Residual Disease Negativity in Multiple Myeloma is Associated With Intestinal Microbiota Composition","volume":"3","author":"Pianko","year":"2019","journal-title":"Blood Adv"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.04.007","article-title":"Gastrointestinal Microbiome and Mycobiome Changes During Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study","volume":"25","author":"El Jurdi","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01702-9","article-title":"Gut Microbiome Correlates of Response and Toxicity Following Anti-CD19 CAR T Cell Therapy","volume":"28","author":"Smith","year":"2022","journal-title":"Nat Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2020.01.009","article-title":"Glucosylsphingosine But Not Saposin C, is the Target Antigen in Gaucher Disease-Associated Gammopathy","volume":"129","author":"Nair","year":"2020","journal-title":"Mol Genet Metab"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.960829\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:46:09Z","timestamp":1656593169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.960829\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":33,"alternative-id":["10.3389\/fimmu.2022.960829"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.960829","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"article-number":"960829"}}